Swiss HLG President chairing panel 'Latest Trends in Dealmaking for Bio-Pharma Panel' - September 26th, 2024, SACHS_BEF

Stay Ahead in Bio-Pharma Dealmaking! Join us for the 'Latest Trends in Dealmaking for Bio-Pharma Panel' at the hashtag#Sachs_BEF on September 26th, 2024, at the Mövenpick Hotel Basel. Discover the strategies driving successful partnerships and transactions in the biopharmaceutical sector.

Co-Chaired by:
Sandra von Meier, Head Business Development & Licensing, Debiopharm International S.A.
Sarah Holland, President of Swiss HLG & CBO, Cureteq AG - a Partex Company

Panellists:
Alessandra Polara, Senior Director, Global BD, F. Hoffmann-La Roche AG
Berthold Hinzen, Global Head BD&L Transactions Immunology, Novartis AG
Jeremy Griggs, Executive Director, Business Development, GSK
Richard Ward, Executive Director, Search & Evaluation, AstraZeneca

This panel offers a deep dive into the evolving landscape of dealmaking in the biopharma industry. Learn from top executives and dealmakers as they explore the latest trends, strategies, and challenges in mergers, acquisitions, and strategic partnerships. Gain insights into how these dynamics are shaping the industry and what it means for future innovation and growth.

Don’t miss this chance to enhance your strategic decision-making and networking capabilities. Secure your spot today at www.sachsforum.com/24bef and join us, both hashtag#inperson & hashtag#online, during the Sachs Autumn Life Sciences Week.